0

Journal Articles

in Drug Therapy
 101-120 of 342 Articles
Capitol Health Call |  May 09, 2012
Seeking Shortage Solutions
Mike Mitka
JAMA. 2012;307(18):1904. doi:10.1001/jama.2012.4002.
Capitol Health Call |  May 09, 2012
Fake Pharmacy Probe
Mike Mitka
JAMA. 2012;307(18):1904. doi:10.1001/jama.2012.4003.
Editorial |  May 09, 2012
Epidemic of Prescription Opiate Abuse and Neonatal Abstinence
Marie J. Hayes, PhD; Mark S. Brown, MD
JAMA. 2012;307(18):1974-1975. doi:10.1001/jama.2012.4526.
Research Letters |  May 09, 2012 FREE
Pediatric Information in Drug Product Labeling
Aaron N. Sachs, BS; Debbie Avant, RPh; Catherine S. Lee, DrPH; et al.
JAMA. 2012;307(18):1914-1915. doi:10.1001/jama.2012.3435.
Viewpoint |  May 09, 2012
New Genetic Discoveries and Treatment for Hepatitis C
Michael Pacanowski, PharmD, MPH; Shashi Amur, PhD; Issam Zineh, PharmD, MPH
JAMA. 2012;307(18):1921-1922. doi:10.1001/jama.2012.3516.
Editorial |  May 02, 2012
The Evolution of Trial Registries and Their Use to Assess the Clinical Trial Enterprise
Kay Dickersin, MA, PhD; Drummond Rennie, MD
JAMA. 2012;307(17):1861-1864. doi:10.1001/jama.2012.4230.
Capitol Health Call |  April 11, 2012
Antibiotic Pipeline
Mike Mitka
JAMA. 2012;307(14):1476. doi:10.1001/jama.2012.414.
Capitol Health Call |  April 11, 2012
Drug Program Probed
Mike Mitka
JAMA. 2012;307(14):1476. doi:10.1001/jama.2012.416.
Health Agencies Update |  March 28, 2012
HIV, Hepatitis Drug Interactions
Bridget M. Kuehn
JAMA. 2012;307(12):1243. doi:10.1001/jama.2012.332.
Medical News and Perspectives |  March 07, 2012
Effects of FDA Safety Warnings May Vary
Bridget M. Kuehn
JAMA. 2012;307(9):894-895. doi:10.1001/jama.2012.217.
Viewpoint |  February 22, 2012
Marketing Pharmaceuticals:  A Constitutional Right to Sell Prescriber-Identified Data?
Lawrence O. Gostin, JD
JAMA. 2012;307(8):787-788. doi:10.1001/jama.2012.182.
Medical News and Perspectives |  February 08, 2012
NIH Program Helps Developers Navigate Path to New Drugs for Neglected Diseases
Rebecca Voelker
JAMA. 2012;307(6):549-550. doi:10.1001/jama.2012.83.
Capitol Health Call |  February 08, 2012
Health Care Fraud
Mike Mitka
JAMA. 2012;307(6):553. doi:10.1001/jama.2012.90.
Editorial |  December 28, 2011
Pharmacogenomics and Clopidogrel:  Irrational Exuberance?
Steven E. Nissen, MD
JAMA. 2011;306(24):2727-2728. doi:10.1001/jama.2011.1865.
Commentary |  December 21, 2011
Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs
Laura J. Esserman, MD, MBA; Janet Woodcock, MD
JAMA. 2011;306(23):2608-2609. doi:10.1001/jama.2011.1837.
Capitol Health Call |  December 14, 2011
Pay for Delay of Generics
Mike Mitka
JAMA. 2011;306(22):2443. doi:10.1001/jama.2011.1767.
From the Centers for Disease Control and Prevention |  December 14, 2011 FREE
QuickStats: Percentage of Adults Aged 18-64 Years Who Did Not Get Needed Prescription Drugs Because of Cost,* by Poverty Status†—National Health Interview Survey, United States, 1999-2010§
JAMA. 2011;306(22):2452. doi:.
JAMA Clinical Challenge |  November 23, 2011 FREE
Acute-Onset Reticulated White Lip
Jeffery B. Shackelton, MD; Joseph C. English, MD
JAMA. 2011;306(20):2267-2268. doi:10.1001/jama.2011.1728.
Capitol Health Call |  November 09, 2011
Foreign Drug Supply Chain
Mike Mitka
JAMA. 2011;306(18):1970. doi:10.1001/jama.2011.1603.
Commentary |  September 21, 2011
Evolving Research and Stakeholder Perspectives on Pharmacogenomics
Amber L. Beitelshees, PharmD, MPH; David L. Veenstra, PharmD, PhD
JAMA. 2011;306(11):1252-1253. doi:10.1001/jama.2011.1343.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems